Targeting Diuretic Use for Malignant Ascites—Two Case Reports Highlighting the Value of the Serum-Ascites Albumin Gradient in a Palliative Setting

References 

1. Campbell C. Controlling malignant ascites. Eur J Palliat Care. 2001;8(5):187–189
2. In:  Doyle D,  Hank G,  Cherny N,  Calman K editor. The Oxford textbook of palliative medicine. 3rd ed.. Oxford, UK: Oxford University Press; 2005;
3. Runyon B, Montano A, Akriviadis A, et al. The serum-ascites albumin gradient is superior to the exudates-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117:215–220
   • MEDLINE
4. Runyon B. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087–2107
   • CrossRef
5. In:  Yamada T,  Alpers DH,  Laine C,  Owyang C,  Powell DW editor. Textbook of gastroenterology. 3rd ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 1999;
6. Lee CW, Bociek G, Faught W. A survey of practice in management of malignant ascites. J Pain Symptom Manage. 1998;16:96–101
   • Abstract
   • Full Text
   • Full-Text PDF (1299 KB)
   • CrossRef
7. Pockros PJ, Esrason KT, Nguyen C, Duque J, Woods S. Mobilization of malignant ascites with diuretics is dependant on ascitic fluid characteristics. Gastroenterology. 1992;103:1302–1306
   • Abstract